7th Apr 2009 07:00
Enfis Group plc
("Enfis" or the "Company")
Final results
The Board of Enfis Group plc is pleased to announce final results for the year ended 31 December 2008.
Contacts
Enfis Group plc +44(0) 1729 485 660
Giles Davies
Noble & Company Limited +44(0) 20 7763 2200
John Llewellyn-Lloyd
James Nelson
Chief Executive Officer's Statement
2008 has seen Enfis emerge as a significant participant in the solid state lighting markets. Having built a strong distribution network in 2007, with 20 distributors covering the major markets of the EU and North America, Enfis switched its focus onto direct sales into the lighting manufacturers and integrators that service lighting manufacturers. As a result, we have successfully engaged with 207 customers in 2008 and experienced a significant increase in revenue. It was particularly pleasing to note the performance of our manufacturing capabilities in the face of this increased demand, particularly for both the UNO and UNO Plus products. Our manufacturing yields achieved our target of 95% and our return rate was well ahead of target at only 0.03%. This is further evidence of the scalability of our business, with the ability to increase output whilst maintaining the excellent quality standards of our product in the market.
Enfis secured relationships with many major lighting companies in all territories in which we operate, and we expect to see many of the developed product lines with those customers become volume sales in 2009.
We have largely completed our portfolio of products with the addition of the Quattro Mini light engine and also a range of optics and drivers for the UNO and UNO Plus range of light engines. We also have developed a number of unique products at the tail end of 2008 that will allow Enfis to further exploit our IP in 2009 and 2010. The products will be announced in 2009 and will include lower cost versions of our platform, and versions with both higher output and higher light quality.
Enfis expects to continue the healthy increase in sales in 2009 based upon relationships and products developed during 2008 and with revenue contributions coming from our North American operation headed by Dan Polito.
Outlook
The Board is pleased with the progress made by the Company and recognises the significant advances that we have made in terms of revenue growth in 2008 and the increased sales pipeline for 2009 and beyond. We have also bolstered the management team with the addition of a Vice President of Sales and Marketing for North America and look forward to the potential growth from that market.
Legislation continues to push for the phasing out of incandescent lighting technology in favour of more efficient lighting. The legislative drives are now beginning to directly affect the markets in North America as well as the EU. The end consumers of lighting products are now becoming much more aware of the opportunities that solid state lighting can bring, and understand the well documented quality and environmental disadvantages that CFL lamps cause.
The Company has also announced its intention to raise approximately £2 million before expenses by means of a placing of 5,600,000 shares at 36p per share. A circular has been posted to shareholders, which includes a Notice of General Meeting to be held on 6 April 2009. These funds will be used to provide additional working capital to allow the Company to address any upside in current revenue forecasts that may occur, and to invest in additional funding in the North American operation, to provide technical assistance to the sales office, which is intended to help accelerate revenue growth.
Even given the current economic climate the long term prospects for Enfis are extremely positive and the Board remains confident of long term growth.
Shaun Oxenham
Chief Executive Officer
Chief Financial Officers Review
The year to 31 December 2008 has been another successful one for Enfis with key metrics achieved in line with market expectations. As expected, the Company is currently expending cash and will continue to do so until a revenue stream is secured which is sufficient to put the business on a stable financial footing. The Board closely manages the Company's cash expenditure and will continue to do so up to and beyond the point that Enfis reaches profitability.
The Company has low levels of both financial and operational gearing, and therefore margin increases achieved will be strongly reflected in the cash balance.
Revenue and margin
Both revenue and margin in 2008 have grown strongly with revenue increasing by 430% on the previous year. Gross margin has strengthened with two product lines now passing through volume production. Management believe that higher production volumes will result in further production efficiencies and a gross margin of circa 50%.
Administrative Expenses
In light of the wider economic downturn, management actively reduced the cost base during Q4 2008 to ensure the business is well placed going into 2009.
Cost reductions were made partly in response to the general economic climate and also in recognition that development of the initial product base is now largely complete, thereby requiring less of a cost base to support the Company going forward.
Balance sheet
Intangible assets relate to patents and development costs which have been capitalised where the specific conditions of IAS 38 have been met. No additional borrowings have been entered into during the period.
There is minimal debt on the balance sheet. This includes a historic bank loan of £88,375 and a finance lease which will be paid off before the end of 2009.
Cash flow
The cash balance at the year end was £640,944, slightly ahead of expectations.
The cash profile is expected to change in the coming year with less cash being spent on development and more being tied up in working capital required to service the expected increase in revenues.
Sources of cash during the year were an injection of equity in February 2008, interest from treasury investment, grant income and the securing of a significant research and development tax credit.
Giles Davies
Chief Financial Officer
Directors' Report
for the year ended 31 December 2008
The directors present the annual report and audited financial statements for the year ended 31 December 2008.
Business review
The principal activity of the Group is the design, development and manufacture of intelligent high power Light Emitting Diode ("LED") arrays and light engines.
The Consolidated Income Statement is set out on page 10.
A review of the group's trading during the year, its position at year-end and its prospects for the future, is set out in the Chief Executive Officer's Statement.
Key performance indicators (KPI's)
Given the straightforward nature and relative size of the business, the Company's directors are of the opinion that analysis using KPI's is not necessary for an understanding of the development, performance or position of the business. The key metrics monitored by the directors include revenue and cash.
Dividends
No dividend is proposed in respect of the year (2007: £nil).
Research and development
Enfis Group plc continues to invest heavily in research and development associated with the design, development and manufacture of intelligent high power light emitting diode arrays and smart light engines. Costs attributed to this process have been charged to the income statement to the extent that they do not meet all the criteria for capitalisation as set out in IAS 38 'Intangible Assets'.
Directors
The directors of the Group, who served during the year are listed below:
Directors |
Function |
Simon Gibson |
Non executive Chairman |
Shaun Oxenham |
Chief Executive Officer |
Giles Davies |
Chief Financial Officer |
Gareth Jones |
Chief Technical Officer |
Drew Nelson |
Non Executive Director |
Ron Jones |
Non Executive Director, Chair of remuneration committee |
John Thynne |
Non Executive Director, Chair of audit committee |
Details of directors interests in share options over the Group's share capital are set out in note 22.
Directors' Report
for the year ended 31 December 2008 (continued)
Employees
The Group's employment policies are designed to attract, retain and motivate the very best staff for each role in the Group, recognising that this can only be achieved through equal opportunities regardless of gender, race, religion or disability.
Regular meetings are held with employees to discuss the performance of the Group as a whole and the area in which they work. Financial and economic factors are dealt with in this context.
Information concerning employees and their remuneration is given in note 19 to the accounts.
Substantial interests
As at 31 December 2008, the Group had been notified, in accordance with Sections 198 to 209 of the Companies Act 1985, of the following substantial interests of 3% or more in the ordinary share capital of the company:
% of ordinary |
|
shares held |
|
Wesley Clover |
18.66 |
Framlington |
13.44 |
Ken Board |
10.15 |
Drew Nelson |
8.63 |
UWS Ventures |
6.39 |
Rathbones |
4.37 |
Robur |
6.23 |
Invesco |
3.72 |
Financial risk management
The directors' assessment of key financial risks and policies in place to mitigate those risks are set out in note 3 to the financial statements.
Donations
No donations were made during the year (2007: £nil).
Events after the balance sheet date
An Extraordinary General Meeting held on 6 April 2009, approved the issue of 5,600,000 £0.10 Ordinary shares, for a consideration of £0.36 per share, generating gross proceeds £2,016,000. The shares will formally be issued on 7 April 2009.
Policy and Practice on Payment of Creditors
The Group and Company aims to settle supplier accounts in accordance with individual suppliers' terms of business. The Group and Company's average number of days' purchases outstanding in respect of trade creditors at 31 December 2008 was 64 days (2007: 33 days).
Directors' Report
for the year ended 31 December 2008 (continued)
Going concern
The directors have concluded, having regard to the most recent projections available that the
group and company will have in place sufficient funding to enable it to continue trading and meet
its liabilities to third parties as they fall due for the foreseeable future.
Statement of directors' responsibilities
The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have prepared the group and parent company financial statements in accordance with International Financial Reporting Standards (IFRSs) as adopted by the European Union. The financial statements are required by law to give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period.
In preparing those financial statements the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and estimates that are reasonable and prudent;
state that the financial statements comply with IFRSs as adopted by the European Union;
prepare the financial statements on a going concern basis unless it is inappropriate to presume that the company will continue in business, in which case there should be supporting assumptions and qualifications as necessary.
The directors are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the company and group and to enable them to ensure that the financial statements comply with the Companies Act 1985. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The directors are responsible for the maintenance and integrity of the group web site, www.enfis.com. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
Each of the directors, whose names and functions are listed in the Directors Report confirm that, to the best of their knowledge:
The group financial statements, which have been prepared in accordance with IFRSs as adopted by the EU, give a true and fair view of the assets, liabilities, financial position and loss of the group; and
The Directors' Report, Chief Executive Officer's Statement and Chief Financial Officer's Statement contained in the Annual Report includes a fair review of the development and performance of the business and the position of the group, together with a description of the principal risks and uncertainties that it faces.
Directors' Report
for the year ended 31 December 2008 (continued)
Disclosure of Information to Auditors
The directors who held office at the date of approval of this Directors' report confirm that, so far as they are aware, there is no relevant audit information of which the Company's auditor is unaware; and each Director has taken all steps that he ought to have taken as a Director to make himself aware of any relevant audit information and to establish that the Company's auditor is aware of that information.
Auditors
The auditors, PricewaterhouseCoopers LLP, have indicated their willingness to continue in office and a resolution concerning their reappointment will be proposed at the Annual General Meeting.
Approved by the Board of Directors
and signed on behalf of the Board
Giles Davies
Company Secretary
Independent auditors' report to the members of Enfis Group plc
We have audited the group and parent company financial statements (the ''financial statements'') of Enfis Group plc for the year ended 31 December 2008 which comprise the Consolidated Income Statement, the Consolidated and Parent Company Balance Sheets, the Consolidated and Parent Company Cash Flow Statements, the Consolidated and Parent Company Statement of Changes in Equity and the related notes. These financial statements have been prepared under the accounting policies set out therein.
Respective responsibilities of directors and auditors
The directors' responsibilities for preparing the Annual Report and the financial statements in accordance with applicable law and International Financial Reporting Standards (IFRSs) as adopted by the European Union are set out in the Statement of Directors' Responsibilities.
Our responsibility is to audit the financial statements in accordance with relevant legal and regulatory requirements and International Standards on Auditing (UK and Ireland). This report, including the opinion, has been prepared for and only for the company's members as a body in accordance with Section 235 of the Companies Act 1985 and for no other purpose. We do not, in giving this opinion, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.
We report to you our opinion as to whether the financial statements give a true and fair view and have been properly prepared in accordance with the Companies Act 1985. We also report to you whether in our opinion the information given in the Directors' Report is consistent with the financial statements. The information given in the Directors' Report includes that specific information presented in the Chief Executive Officer's Statement that is cross referred from the Business Review section of the Directors' Report.
In addition we report to you if, in our opinion, the company has not kept proper accounting records, if we have not received all the information and explanations we require for our audit, or if information specified by law regarding directors' remuneration and other transactions is not disclosed.
We read other information contained in the Annual Report and consider whether it is consistent with the audited financial statements. The other information comprises only the Directors' Report, the Chief Executive's Statement and the Chief Financial Officer's Statement. We consider the implications for our report if we become aware of any apparent misstatements or material inconsistencies with the financial statements. Our responsibilities do not extend to any other information.
Basis of audit opinion
We conducted our audit in accordance with International Standards on Auditing (UK and Ireland) issued by the Auditing Practices Board. An audit includes examination, on a test basis, of evidence relevant to the amounts and disclosures in the financial statements. It also includes an assessment of the significant estimates and judgements made by the directors in the preparation of the financial statements, and of whether the accounting policies are appropriate to the group's and company's circumstances, consistently applied and adequately disclosed.
We planned and performed our audit so as to obtain all the information and explanations which we considered necessary in order to provide us with sufficient evidence to give reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or other irregularity or error. In forming our opinion we also evaluated the overall adequacy of the presentation of information in the financial statements.
Independent auditors' report to the members of Enfis Group plc
Opinion
In our opinion:
the group financial statements give a true and fair view, in accordance with IFRSs as adopted by the European Union, of the state of the group's affairs as at 31 December 2008 and of the group's loss and cash flows for the year then ended;
the parent company financial statements give a true and fair view, in accordance with IFRSs as adopted by the European Union as applied in accordance with the provisions of the Companies Act 1985, of the state of the parent company's affairs as at 31 December 2008 and cash flows for the year then ended;
the financial statements have been properly prepared in accordance with the Companies Act 1985; and
the information given in the Directors' Report is consistent with the financial statements.
PricewaterhouseCoopers LLP
Chartered Accountants and Registered Auditors
Cardiff
Consolidated income statement - by function of expense
for the year ended 31 December 2008
Notes |
2008 £ |
2007 £ |
|
Revenue |
5 |
1,628,002 |
307,013 |
Cost of sales |
(1,023,458) |
(268,906) |
|
Gross profit |
604,544 |
38,107 |
|
Administrative expenses |
(2,608,107) |
(2,308,737) |
|
Other income |
72,717 |
140,235 |
|
Operating loss |
(1,930,846) |
(2,130,395) |
|
Finance income |
20 |
54,434 |
124,215 |
Finance costs |
21 |
(21,332) |
(40,685) |
33,102 |
83,530 |
||
Loss before income tax |
(1,897,744) |
(2,046,865) |
|
Income tax credit |
23 |
555,789 |
181,812 |
Loss for the year |
(1,341,955) |
(1,865,053) |
|
Attributable to: |
|||
Equity holders of the company |
(1,341,955) |
(1,865,053) |
|
Loss per share for loss attributable to the equity holders of the company during the year |
|||
- basic and diluted |
(14.4p) |
(22.7p) |
|
The results relate to continuing operations.
The company has elected to take the exemption under section 230 of the Companies Act 1985 to not present the parent company income statement.
The loss for the parent company for the year was £82,332 (2007: £61,749).
The notes on pages 16 to 44 are an integral part of these consolidated financial statements.
Consolidated balance sheet
As at 31 December 2008
Notes |
2008 £ |
2007 £ |
|
Assets |
|||
Non current assets |
|||
Property, plant and equipment |
7 |
217,575 |
235,351 |
Intangible assets |
8 |
540,447 |
399,934 |
758,022 |
635,285 |
||
Current assets |
|||
Inventories |
9 |
351,108 |
277,876 |
Trade and other receivables |
10 |
218,373 |
211,862 |
Corporation tax receivable |
271,392 |
- |
|
Cash and cash equivalents |
11 |
640,944 |
1,999,424 |
1,481,810 |
2,489,162 |
||
Total assets |
2,239,839 |
3,124,447 |
|
Equity |
|||
Capital and reserves attributable to equity holders of the Company |
|||
Ordinary shares |
12 |
938,286 |
893,606 |
Share premium |
12 |
4,067,413 |
3,585,446 |
Share option reserve |
144,081 |
61,749 |
|
Reverse acquisition reserve |
2,283,667 |
2,283,667 |
|
Retained losses |
(5,767,313) |
(4,425,358) |
|
Total equity |
1,666,126 |
2,399,110 |
|
Liabilities |
|||
Non-current liabilities |
|||
Deferred income |
14 |
35,000 |
65,748 |
Borrowings |
15 |
58,075 |
106,105 |
93,075 |
171,853 |
||
Current liabilities |
|||
Trade and other payables |
13 |
432,600 |
495,046 |
Borrowings |
15 |
48,030 |
58,438 |
480,630 |
553,484 |
||
Total liabilities |
573,705 |
725,337 |
|
Total equity and liabilities |
2,239,839 |
3,124,447 |
The notes on pages 16 to 44 are an integral part of these consolidated financial statements.
The financial statements were approved and authorised for issue by the board and were signed on its behalf on 6 April 2009.
Director
Parent company balance sheet
As at 31 December 2008
Notes |
2008 £ |
2007 £ |
|
Assets |
|||
Non current assets |
|||
Investments |
6 |
572,175 |
572,175 |
Trade and other receivables |
10 |
4,433,522 |
3,906,875 |
5,005,697 |
4,479,050 |
||
Current assets |
|||
Cash and cash equivalents |
11 |
2 |
2 |
2 |
2 |
||
Total assets |
5,005,699 |
4,479,052 |
|
Equity |
|||
Capital and reserves attributable to equity holders of the Company |
|||
Ordinary shares |
12 |
938,286 |
893,606 |
Share premium |
4,067,413 |
3,585,446 |
|
Share option reserve |
144,081 |
61,749 |
|
Retained losses |
(144,081) |
(61,749) |
|
Total equity |
5,005,699 |
4,479,052 |
|
Liabilities |
|||
Non-current liabilities |
|||
Deferred income |
14 |
- |
- |
Borrowings |
15 |
- |
- |
- |
- |
||
Current liabilities |
|||
Trade and other payables |
13 |
- |
- |
Borrowings |
15 |
- |
- |
- |
- |
||
Total liabilities |
- |
- |
|
Total equity and liabilities |
5,005,699 |
4,479,052 |
The notes on pages 16 to 44 are an integral part of these financial statements.
The financial statements were approved and authorised for issue by the board and were signed on its behalf on 6 April 2009.
Director
Consolidated and parent company cash flow statements
for the year ended 31 December 2008
Notes |
Group 2008 £ |
Group 2007 £ |
Company 2008 £ |
Company 2007 £ |
|
Cash flows from operating activities |
|||||
Cash used in operations |
26 |
(1,811,691) |
(2,236,731) |
- |
- |
Interest paid |
(21,332) |
(40,685) |
- |
- |
|
Tax received |
284,419 |
182,787 |
- |
- |
|
Net cash used in operating activities |
(1,548,604) |
(2,094,629) |
- |
- |
|
Cash flows from investing activities |
|||||
Purchase of property, plant and equipment |
(58,702) |
(103,567) |
- |
- |
|
Purchase of intangible assets |
(315,787) |
(380,657) |
- |
- |
|
Receipt of government grants |
41,969 |
154,604 |
- |
- |
|
Loans granted to subsidiary undertakings |
- |
- |
(526,647) |
(3,906,875) |
|
Interest received |
54,434 |
124,215 |
- |
- |
|
Net cash used in investing activities |
(278,086) |
(205,405) |
(526,647) |
(3,906,875) |
|
Cash flows from financing activities |
|||||
Proceeds from the issuance of ordinary shares |
526,648 |
4,143,890 |
526,647 |
3,906,877 |
|
Repayments of borrowings |
(30,300) |
(30,300) |
- |
- |
|
Finance lease principal repayments |
(28,138) |
(32,914) |
- |
- |
|
Net cash generated from financial activities |
468,210 |
4,080,676 |
526,647 |
3,906,877 |
|
Net (decrease) / increase in cash and cash equivalents |
(1,358,480) |
1,780,642 |
- |
2 |
|
Cash and cash equivalents at the beginning of the year |
1,999,424 |
218,782 |
2 |
- |
|
Cash and cash equivalents at the end of the year |
640,944 |
1,999,424 |
2 |
2 |
The notes on pages 16 to 44 are an integral part of these financial statements.
Consolidated statement of changes in equity
for the year ended 31 December 2008
Group |
Ordinary share capital |
Deferred share capital |
Capital redemption reserve |
Preference shares (equity element) |
Share premium |
Share option reserve |
Share warrants |
Reverse acquisition reserve |
Retained losses |
Total |
£ |
£ |
£ |
£ |
£ |
£ |
£ |
£ |
£ |
£ |
|
Balance at 1 January 2007 |
1,820 |
- |
- |
77,792 |
2,553,992 |
221,254 |
30 |
- |
(2,913,068) |
(58,180) |
Conversion of preference shares |
87 |
299,913 |
- |
(77,792) |
- |
- |
- |
- |
131,509 |
353,717 |
Share issue and redemption of deferred shares |
- |
(299,913) |
299,913 |
- |
- |
- |
- |
- |
- |
- |
Allotment of shares |
2 |
- |
- |
- |
- |
- |
- |
- |
- |
2 |
Share for share exchange (Enfis Group plc with Enfis Limited) |
572,175 |
- |
- |
- |
- |
- |
- |
(572,175) |
- |
- |
Reverse Acquisition adjustments |
(1,907) |
- |
(299,913) |
- |
(2,553,992) |
- |
(30) |
2,855,842 |
- |
- |
AIM listing (Issue of new shares) |
321,429 |
- |
- |
- |
4,178,571 |
- |
- |
- |
- |
4,500,000 |
Expenses incurred on issue of new shares |
- |
- |
- |
- |
(593,125) |
- |
- |
- |
- |
(593,125) |
Share option reversal |
- |
- |
- |
- |
- |
(221,254) |
- |
- |
221,254 |
- |
Loss for the period |
- |
- |
- |
- |
- |
61,749 |
- |
- |
(1,865,053) |
(1,803,304) |
Balance at 31 December 2007 |
893,606 |
- |
- |
- |
3,585,446 |
61,749 |
- |
2,283,667 |
(4,425,358) |
2,399,110 |
Issue of new shares |
44,680 |
- |
- |
- |
481,967 |
- |
- |
- |
- |
526,647 |
Share option reversal loss for the year |
- |
- |
- |
- |
- |
82,332 |
- |
- |
- |
82,332 |
Loss for period |
- |
- |
- |
- |
- |
- |
- |
- |
(1,341,955) |
(1,341,955) |
Balance at 31 December 2008 |
938,286 |
- |
- |
- |
4,067,413 |
144,081 |
- |
2,283,667 |
(5,767,313) |
1,666,134 |
The capital redemption reserve has arisen on conversion of the convertible preference shares under the capital maintenance provisions of IAS21.
The reverse acquisition reserve arose on the acquisition by Enfis Group plc of the entire issued share capital of Enfis Limited on 16 March 2007. The consideration payable in respect of the transaction was settled via a share for share exchange, whereby three ordinary shares in Enfis Group plc were exchanged for each allotted share in Enfis Limited. This group reconstruction has been accounted for as a reverse acquisition in accordance with IFRS 3, 'Business Combinations'.
The notes on pages 16 to 44 are an integral part of these financial statements.
Parent company statement of changes in equity for the year ended 31 December 2008
Company |
Ordinary share capital |
Deferred share capital |
Capital redemption reserve |
Preference shares (equity element) |
Share premium |
Share option reserve |
Share warrants |
Reverse acquisition reserve |
Retained losses |
Total |
£ |
£ |
£ |
£ |
£ |
£ |
£ |
£ |
£ |
£ |
|
Balance at 17 March 2007 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Allotment of shares (On incorporation) |
2 |
- |
- |
- |
- |
- |
- |
- |
- |
2 |
Share for share exchange (Enfis Group plc with Enfis Limited) |
572,175 |
- |
- |
- |
- |
- |
- |
- |
- |
572,175 |
AIM listing (Issue of new shares) |
321,429 |
- |
- |
- |
4,178,571 |
- |
- |
- |
- |
4,500,000 |
Expenses incurred on issue of new shares |
- |
- |
- |
- |
(593,125) |
- |
- |
- |
- |
(593,125) |
Loss for the period |
- |
- |
- |
- |
- |
61,749 |
- |
- |
(61,749) |
- |
Balance at 31 December 2007 |
893,606 |
- |
- |
- |
3,585,446 |
61,749 |
- |
- |
(61,749) |
4,479,052 |
Issue of new shares |
44,680 |
- |
- |
- |
481,967 |
- |
- |
- |
- |
526,647 |
Loss for the year |
- |
- |
- |
- |
- |
82,332 |
- |
- |
(82,332) |
- |
Balance at 31 December 2008 |
938,286 |
- |
- |
- |
4,067,413 |
144,081 |
- |
- |
(144,081) |
5,005,699 |
The capital redemption reserve has arisen on conversion of the convertible preference shares under the capital maintenance provisions of IAS21.
The reverse acquisition reserve arose on the acquisition by Enfis Group plc of the entire issued share capital of Enfis Limited on 16 March 2007. The consideration payable in respect of the transaction was settled via a share for share exchange, whereby three ordinary shares in Enfis Group plc were exchanged for each allotted share in Enfis Limited. This group reconstruction has been accounted for as a reverse acquisition in accordance with IFRS 3, 'Business Combinations'.
The notes on pages 16 to 44 are an integral part of these financial statements.
Notes to the financial statements
for the year ended 31 December 2008
1 General information
The principal activity of the group is the design, development, manufacture and sale of light emitting diode based arrays and light engines.
The company is a public limited liability company incorporated and domiciled in England and Wales and listed on the Alternative Investment Market ('AIM').
The directors consider there to be no ultimate controlling shareholder of the company.
The address of the registered office is Technium 2, Kings Road, Swansea Waterfront, Swansea, SA1 8PJ and the registered number of the company is 06133765.
2 Summary of significant accounting policies
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
2.1 Basis of preparation
The consolidated financial statements of Enfis Group plc have been prepared in accordance with the requirements of the AIM rules and in accordance with International Financial Reporting Standards as adopted by the European Union, IFRIC interpretations, the historical cost convention and the Companies Act 1985.
The preparation of financial statements in conformity with IFRS requires the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the group's accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the consolidated financial statements are disclosed in note 4.
(a) Going concern
The directors have concluded, having regard to the most recent projections available that the
group and company will have in place sufficient funding to enable it to continue trading and meet
its liabilities to third parties as they fall due for the foreseeable future.
(b) Interpretations effective in 2008
IFRIC 11, 'IFRS 2 - Group and treasury share transactions', provides guidance on whether share based transactions involving treasury shares or involving group entities (for example, options over a parent's shares) should be accounted for as equity settled or cash settled share based payment transactions in the stand alone accounts of the parent and group companies. This interpretation does not have an impact on the group's financial statements. The company's accounting policy for share based compensation arrangements is already in compliance with the interpretation.
(c) Standards, amendments and interpretations effective in 2008 but not relevant
The following standards, amendments and interpretations to published standards are mandatory for accounting periods beginning on or after 1 January 2008 but they are not relevant to the group or company's operations.
IFRIC 12 'service concession arrangements'
IFRIC 13, 'customer loyalty programmes; and
IFRIC 14, 'IAS 19 - the limit on a deferred benefit asset, minimum funding requirements and their interaction'.
2 Summary of significant accounting policies (continued)
(d) Interpretations to existing standards that are not yet effective and have not been early adopted by the company
The following standards and amendments to existing standards have been published and are mandatory for the group's accounting periods beginning on or after 1 January 2009 or later periods, but the group has not early adopted them.
IAS 23 (amendment), 'Borrowing costs' (effective from 1 January 2009). The amendment to the standard is still subject to endorsement by the EU. It requires an entity to capitalise borrowing costs directly attributable to the acquisition, construction or production of a qualifying asset (one that takes a substantial period of time to get ready for use or sale) as part of the cost of that asset. The option of immediately expensing those borrowing costs will be removed. The group and company will apply IAS 23 (amendment) retrospectively from 1 January 2009, subject to endorsement by the EU, but the amendment is currently not applicable to the group or company as there are no qualifying assets.
IAS 1 (revised). 'Presentation of financial statements' (effective from 1 January 2009). The standard is still subject to endorsement by the EU. The revised standard will prohibit the presentation of items of income and expenses (that is, 'non-owner changes in equity') in the statement of changes in equity, requiring non owner changes in equity to be presented separately from owner changes in equity. All non owner changes in equity will be required to be shown in a performance statement, but entities can choose whether to present one performance statement (the statement of comprehensive income) or two statements (the income statement and statement of comprehensive income). Where entities restate or reclassify comparative information, they will be required to present a restated balance sheet as at the beginning comparative period in addition to the current requirement to present balance sheets at the end of the current period and comparative period. The group and company will apply IAS 1 (revised) from 1 January 2009, subject to endorsement by the EU. It is likely that both the income statement and statement of comprehensive income will be presented as performance statements.
IFRS 2 (amendment), 'Share based payment' (effective from 1 January 2009). The amendment to the standard is still subject to endorsement by the EU. It deals with vesting conditions and cancellations. It clarifies that vesting conditions are service conditions and performance conditions only. Other features of a share based payment are not vesting conditions. These features would need to be included in the grant date fair value for transactions with employees and others providing similar services; they would not impact the number of awards expected to vest or valuation there of subsequent to grant date. All cancellations, whether by the entity or by other parties, should receive the same accounting treatment. The group and company will apply IFRS 2 (amendment) from 1 January 2009, subject to endorsement by the EU. It is not expected to have a material impact on the group or company's financial statements.
IAS 32 (amendment), 'Financial instruments: Presentation', and IAS 1 (amendment), 'Presentation of financial statements' - 'Putable financial instruments and obligations arising on liquidation' (effective from 1 January 2009). The amendment to the standard is still subject to endorsement by the EU. It requires entities to classify putable financial instruments and instruments, or components of instruments that impose on the entity an obligation to deliver another party a pro rata share of the net assets of the entity only on liquidation as equity, provided the financial instruments have particular features and meet specific conditions. The group will apply the IAS 32 and IAS 1(amendment) from 1 January 2009, subject to endorsement by the EU. It is not expected to have any impact on the group or company's financial statements.
2 Summary of significant accounting policies (continued)
IFRS 1 (amendment), 'First time adoption of IFRS', and IAS 27, 'Consolidated and separate financial statements', (effective from 1 January 2009). The revised standard is still subject to endorsement by the EU. The amended standard allows first time adopters to use a deemed cost of either fair value or the carrying amount under previous accounting practice to measure the initial cost of investments in subsidiaries, jointly controlled entities and associates in the separate financial statements. The amendment also removes the definition of the cost method from IAS 27 and replaces it with a requirement to present dividends as income in the separate financial statements of the investor. The group will apply IFRS 1 (amendment) from 1 January 2009, subject to endorsement by the EU. The amendment will not have any impact on the group or company's financial statements which are already prepared under IFRS.
IAS 27 (revised), 'Consolidated and separate financial statements', (effective from 1 July 2009). The amendment to the standard is still subject to endorsement by the EU. The revised standard requires the effects of all transactions with non controlling interests to be recorded in equity if there is no change in control and these transactions will no longer result in goodwill or gains and losses. The standard also specifies the accounting when control is lost. Any remaining interest in the entity is re-measured to fair value, and a gain or loss is recognised in profit or loss. The group will apply IAS 27 (revised) prospectively to transactions with non controlling interests from 1 January 2010, subject to endorsement by the EU.
IFRS 3 (revised), 'Business combinations' (effective from 1 July 2009). The revised standard is still subject to endorsement by the EU. The revised standard continues to apply the acquisition method to business combinations, with some significant changes. For example, all payments to purchase a business are to be recorded at fair value at the acquisition date, with contingent payments classified as debt subsequently re-measured through the income statement. There is a choice on an acquisition by acquisition basis to measure the non controlling interest in the acquiree either at fair value or at the non controlling interest's proportionate share of the acquiree's net assets. All acquisition related costs should be expensed. The group will apply IFRS 3 (revised) prospectively to all business combinations from 1 January 2010, subject to endorsement by the EU.
IFRS 5 (amendment), 'Non-current assets held-for-sale and discontinued operations', (and consequential amendment to IFRS 1, 'First time adoption') (effective from 1 July 2009). The amendment is part of the IASB's annual improvements project published in May 2008. The amendment to the standard is still subject to endorsement by the EU. The amendment clarifies that all of a subsidiary's assets and liabilities are classified as held for sale if a partial disposal sale plan results in loss of control. Relevant disclosure should be made for this subsidiary if the definition of a discontinued operation is met. A consequential amendment to IFRS 1 states that these amendments are applied prospectively from the date of transition to IFRS's. The group will apply the IFRS 5 (amendment) prospectively to all partial disposals of subsidiaries from 1 January 2010, subject to endorsement by the EU.
IAS 23 (amendment), 'Borrowing costs' (effective from 1 January 2009). The amendment is part of the IASB's annual improvements project published in May 2008. The amendment to the standard is still subject to endorsement by the EU. The definition of borrowing costs has been amended so that interest expense is calculated using the effective interest method defined in IAS 39 'Financial instruments: Recognition and measurement'. This eliminates the inconsistency of terms between IAS 39 and IAS 23. The group and company will apply the IAS 23 (amendment) prospectively to the capitalisation of borrowing costs on qualifying assets from 1 January 2009, subject to endorsement by the EU, but is currently not applicable to the group or company as there are no qualifying assets.
2 Summary of significant accounting policies (continued)
IAS 28 (amendment), 'Investments in associates' (and consequential amendments to IAS 32, 'Financial Instruments: Presentation', and IFRS 7, 'Financial instruments: Disclosures') (effective from 1 January 2009). The amendment is part of the IASB's annual improvements project published in May 2008. The amendment to the standard is still subject to endorsement by the EU. An investment in associate is treated as a single asset for the purposes of impairment testing. Any impairment loss is not allocated to specific assets included within the investment, for example, goodwill. Reversals of impairment are recorded as an adjustment to the investment balance to the extent that the recoverable amount of the associate increases. The group will apply the IAS 28 (amendment) to impairment tests related to investments in associates and any related impairment losses from 1 January 2009, subject to endorsement by the EU, but are currently not applicable to the group or company as there are no investments in associates.
IAS 36 (amendment), 'Impairment of assets', (effective from 1 January 2009). The amendment is part of the IASB's annual improvements project published in May 2008. The amendment to the standard is still subject to endorsement by the EU. Where fair value less costs to sell is calculated on the basis of discounted cash flows, disclosures equivalent to those for value in use calculation should be made. The group and company will apply the IAS 36 (amendment) and provide the required disclosure where applicable for impairment tests from 1 January 2009, subject to endorsement by the EU.
IAS 38 (amendment), 'Intangible assets', (effective from 1 January 2009). The amendment is part of the IASB's annual improvements project published in May 2008. The amendment to the standard is still subject to endorsement by the EU. A prepayment may only be recognised in the event that payment has been made in advance of obtaining right of access to goods or receipt of services. The group will apply the IAS38 (amendment) from 1 January 2009, subject to endorsement by the EU.
IAS 19 (amendment), 'Employee benefits', (effective from 1 January 2009). The amendment is part of the IASB's annual improvements project published in May 2008. The amendment to the standard is still subject to endorsement by the EU.
The group will apply the IAS 19 (amendment) from 1 January 2009, subject to endorsement by the EU. The amendment will not have an impact on the group or company's financial statements as it does not operate a defined benefit obligation.
2 Summary of significant accounting policies (continued)
IAS 39 (amendment), 'Financial instruments: Recognition and measurement' (effective from 1 January 2009). The amendment is part of the IASB's annual improvements project published in May 2008. The amendment to the standard is still subject to endorsement by the EU.
The group any company will apply the IAS 39 (amendment) from 1 January 2009, subject to endorsement by the EU. It is not expected to have an impact on the group or company's income statement.
IAS 1 (amendment), 'Presentation of financial statements', (effective from 1 January 2009). The amendment is part of the IASB's annual improvements project published in May 2008. The amendment to the standard is still subject to endorsement by the EU. The amendment clarifies that some rather than all financial assets and liabilities classified as held for trading in accordance with IAS 39, 'Financial instruments: Recognition and measurement' are examples of current assets and liabilities respectively. The group and company will apply the IAS 39 (amendment) from 1 January 2009, subject to endorsement by the EU. It is not expected to have an impact on the group or company's financial statements.
IAS 20 (amendment), 'Accounting for government grants and disclosure of government assistance' (effective from 1 January 2009). The benefit of a below market rate government loan is measured at the difference between the carrying amount in accordance with IAS 29, 'Financial instruments: Recognition and measurement', and the proceeds received with the benefit accounted for in accordance with IAS 20. The amendment is not expected to have a material impact on the group and companies financial statements.
There are a number of minor amendments to IFRS 7, 'Financial instruments: Disclosures', IAS 8, 'Accounting policies, changes in accounting estimates and errors', IAS 10, 'Events after the reporting period', IAS 18, 'Revenue', and IAS 34, 'Interim financial reporting', which are part of the IASB's annual improvements project published in May 2008 (not addressed above). The amendments to the standards are still subject to endorsement by the EU. These amendments, subject to endorsement by the EU, are unlikely to have an impact on the group or company's accounts and have, therefore, not been analysed in detail.
2 Summary of significant accounting policies (continued)
IFRIC 16, 'Hedges of a net investment in a foreign operation' (effective from 1 October 2008). The amendment to the interpretation is still subject to endorsement by the EU. IFRIC 16 clarifies the accounting treatment in respect of net investment hedging. This includes the fact that net investment hedging relates to differences in functional currency not presentation currency, and hedging instruments may be held anywhere in the group. The requirements of IAS 21, 'The effects of changes in foreign exchange rates', do apply to the hedged item. The group will apply IFRIC 16 from 1 January 2009. It is not expected to have an impact on the group or company's financial statements.
IFRS 8, 'Operating segments' (effective from 1 January 2009). IFRS 8 replaces IAS 14, 'Segment reporting'. The new standard requires a 'management approach', under which segment information is presented on the same basis as that used for internal reporting purposes. The new standard is not expected to have a material impact on the group and companies financial statements.
2.2 Consolidation
Subsidiaries
Subsidiaries are all entities over which the company has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. The existence and effect of potential voting rights that are currently exercisable or convertible are considered when assessing whether the group controls another entity. Subsidiaries are fully consolidated from the date on which control is transferred to the group. They are de-consolidated from the date that control ceases.
2.3 Segmental reporting
A business segment is a group of assets and operations engaged in providing products or services that are subject to risks and returns that are different from those of other business segments. A geographical segment is engaged in providing products or services within a particular economic environment that are subject to risks and returns which are different from those of segments operating in other economic environments.
2.4 Foreign currency translation
The functional currency of the company is sterling. Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at year end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the income statement.
2.5 Intangible fixed assets - patents and development costs
Acquired patents associated with internally developed intellectual property are shown at historical cost. Patents have a finite useful life and are carried at cost less accumulated amortisation. Amortisation is calculated using the straight-line method to allocate the cost over their estimated useful lives (5 years).
The costs associated with acquiring patents relating to technology which are no longer integral to the product range planned for market are expensed to the income statement.
Development costs capitalised under IAS38 are carried at historical cost. Development costs have a finite useful life and are carried at cost less accumulated amortisation. Amortisation is calculated using the straight-line method to allocate the cost over their estimated useful lives (5 years).
Intangible amortisation is recognised within administrative expenses in the income statement.
2 Summary of significant accounting policies (continued)
2.6 Property, plant and equipment
All property, plant and equipment is stated at historical cost less accumulated depreciation. The cost of property, plant and equipment includes expenditure that is directly attributable to the acquisition of the assets.
Depreciation on all property, plant and equipment is calculated using the straight-line method to allocate their cost to their residual values over their estimated useful lives, as follows:
Plant and machinery 20%
Fixture and fittings 20%
The assets' residual values and useful lives are reviewed and adjusted, if appropriate, at each balance sheet date.
An asset's carrying amount is written down immediately to its recoverable amount if the asset's carrying amount is greater than its estimated recoverable amount.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised within 'Other net (losses)/gains in the income statement.
Repairs and maintenance expenditure is written off to the income statement account as incurred.
2.7 Research and development
Expenditure on research is charged to the income statement as incurred.
Expenditure on product development is capitalised as an intangible asset in the balance sheet from the date that the expenditure incurred on the development meets all the capitalisation criteria as set out in IAS 38 `Intangible assets' and detailed below:
Technical feasibility of completing the asset so that it will be available for use or sale can be demonstrated;
The intention to complete the asset and use or sell it can be demonstrated;
The ability to use or sell the asset can be demonstrated;
The ability to demonstrate how the asset will generate probable future economic benefits;
The ability to demonstrate the availability of adequate technical, financial and other resources to complete the development and to use or sell the asset; and
The ability to measure reliably the expenditure attributable to the asset during its development.
Expenditure on product development is expensed to the income statement as incurred where the capitalisation criteria in IAS 38 are not met. Development costs recognised as an expense are not recognised as an asset in a subsequent period.
2 Summary of significant accounting policies (continued)
2.8 Financial assets
The company has a single class of financial asset which is classified as trade and other receivables. The classification depends on the purpose for which the financial assets were acquired and management determines the classification of its financial assets at initial recognition.
Trade and other receivables are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They are classified as 'trade and other receivables' in the balance sheet and are included in current assets, except for maturities greater than 12 months after the balance sheet date. These are classified as non-current assets.
2.9 Trade receivables
Trade receivables are recognised initially at fair value and subsequently measured at amortised cost using the effective interest rate method, less provision for impairment. A provision for impairment of trade receivables is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables. Significant financial difficulties of the debtor, probability that the debtor will enter bankruptcy or financial reorganisation, and default or delinquency in payment are considered indicators that the trade receivable is impaired. The carrying amount of the asset is reduced through the use of a provision account, and the amount of the loss is recognised within administrative expenses in the income statement.
2.10 Inventories
Inventories are stated at the lower of cost and net realisable value. Cost is determined using the first in, first out method. The cost of finished goods comprises the purchase price including transport and handling costs.
Net realisable value is the estimated selling price in the ordinary course of business, less applicable variable selling expenses.
2.11 Cash and cash equivalents
Cash and cash equivalents includes cash in hand, deposits held at call with banks and other short-term highly liquid investments, with original maturities of three months or less. Bank overdrafts are shown within borrowings in current liabilities on the balance sheet.
2.12 Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.13 Trade payables
Trade payables are non derivative financial liabilities with fixed or determinable payments. Trade payables are included in current liabilities, except for maturities greater than 12 months after the balance sheet date. These are classified as non current liabilities. Trade payables are recognised initially at fair value and subsequently measured at amortised cost using the effective interest rate method.
2 Summary of significant accounting policies (continued)
2.14 Borrowings
Borrowings are recognised initially at fair value, net of transaction costs incurred. Borrowings are subsequently stated at amortised cost with any difference between the proceeds (net of transaction costs) and the redemption value recognised in the income statement over the period of the borrowings using the effective interest rate method.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least 12 months after the balance sheet date.
2.15 Current and deferred income tax
The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the balance sheet date in the countries where the company's subsidiaries and associates operate and generate taxable income. Management periodically evaluates positions taken in tax returns with respect to situations in which applicable tax regulation is subject to interpretation and establishes provisions where appropriate on the basis of amounts expected to be paid to the tax authorities.
Deferred income tax is provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements. However, deferred income tax is not accounted for if it arises from initial recognition of an asset or liability in a transaction other than a business combination that at the time of the transaction affects neither accounting nor taxable profit nor loss. Deferred income tax is determined using tax rates (and laws) that have been enacted or substantively enacted by the balance sheet date and are expected to apply when the related deferred income tax asset is realised or the deferred income tax liability is settled.
Deferred income tax assets are recognised to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilised.
2.16 Revenue
Revenue comprises the fair value of the consideration received or receivable for the sale of goods and services or consideration receivable from cooperative partners for product development in the ordinary course of the company's activities. Revenue is shown net of value added taxes, returns and rebates.
Revenue is recognised when the amount can be reliably measured and it is probable that future economic benefit will flow to the company under the terms of any sale agreements. Revenue is not considered to be reliably measurable until all contingent clauses in sale agreements are met. Revenue is recognised when goods are invoiced, this normally corresponds to the date that goods are despatched to customers.
2.17 Government grants
Grants from the government are recognised at their fair value where there is reasonable assurance that the grant will be received and that the company will comply with all attached conditions.
Government grants relating to costs are deferred and recognised in other income in the income statement over the period necessary to match them with the costs that they are intended to compensate.
Capital grants that relate to specific capital expenditure are included in current and non-current liabilities as deferred income which is credited to the income statement over the related asset's useful life.
2 Summary of significant accounting policies (continued)
2.18 Leasing and hire purchase commitments
Assets held under finance leases, which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet and are depreciated over the shorter of their useful lives and the lease term.
The interest elements of the rental obligations are charged in the income statement over the periods of the leases and hire purchase contracts and represent a constant proportion of the balance of capital repayments outstanding.
Leases in which a significant portion of the risks and rewards of ownership are retained by the lessor are classified as operating leases. Rentals payable under operating leases are charged in the income statement on a straight line basis over the lease term.
2.19 Share based payments
The Company operates an equity-settled, share-based compensation plan. The fair value of the employee services received in exchange for the grant of the options is recognised as an expense. The total amount to be expensed over the vesting period is determined by reference to the fair value of the options granted, excluding the impact of any non-market vesting conditions (for example, profitability and sales growth targets). Non-market vesting conditions are included in assumptions about the number of options that are expected to vest. At each balance sheet date, the entity revises its estimates of the number of options that are expected to vest. It recognises the impact of the revision to original estimates, if any, in the income statement with a corresponding adjustment to equity.
The proceeds received net of any directly attributable transaction costs are credited to share capital (nominal value) and share premium when the options are exercised.
3 Financial risk
3.1 Financial risk factors
The company's operations expose it to a variety of financial risks that include the effects of credit risk, liquidity risk and interest rate risk. The company has in place a risk management programme that seeks to limit the adverse effects on the financial performance of the company by monitoring levels of debt finance and the related finance costs. The company does not use derivative financial instruments to manage interest rate costs and as such, no hedge accounting is applied.
Given the size of the company, the directors have not delegated the responsibility of monitoring financial risk management to a sub-committee of the board. The policies set by the board of directors are implemented by the company's finance department.
(a) Market Risk
(i) Foreign exchange risk
The group distributes and sells internationally and is exposed to foreign exchange risk arising from various currency exposures, primarily with respect to the US dollar and UK pound. Foreign exchange risk arises from future commercial transactions and translation of foreign currency denominated monetary assets and liabilities. Foreign currency risk is managed via the purchase of raw materials and the sale of products in equivalent currencies.
3 Financial risk (continued)
3.1 Financial risk factors (continued)
(ii) Price risk
The company has periodic price reviews within distributor sales contracts that enable the company to reassess and adjust for price risk as part of contractual negotiations. Commodity price risk is assessed as low as a result of the various supply alternatives available for key components.
(b) Credit risk
The company has implemented policies that require appropriate credit checks on potential customers before sales are made. The company's credit risk is primarily attributable to its trade receivables balance. The amounts presented in the balance sheet are net of allowances for impairment.
(c) Liquidity risk
The company utilises medium-term debt finance, principally a floating rate bank loan guaranteed under the Small Firm Loan Guarantee Scheme.
(d) Interest rate cash flow risk
The company has both interest bearing assets and interest bearing liabilities. Interest bearing assets comprise only cash balances, which earn interest at fixed and floating rates. Interest bearing liabilities comprise debt at fixed and floating rates.
4 Critical accounting estimates and judgements
In the preparation of the financial information the directors must make estimates and assumptions that effect the asset and liability items and revenue and expense amounts recorded in the financial information. These estimates are based on historical experience and various other assumptions that the Board believe are reasonable under the circumstances. The results of this form the basis for making judgements about the carrying value of assets and liabilities that are not readily available from other sources.
Development expenditure
The principal area where judgement has been exercised in relation to the financial statements is in respect of development costs. The company has incurred £1,235,281 of product development costs in the year ended 31 December 2007 and £1,076,016 of product development costs in the year ended 31 December 2008. Of the total development costs incurred in the year ended 31 December 2008, an amount of £269,658 has been capitalised (2007: £359,613). Development costs are expensed to the income statement where the Board believes that all the criteria for capitalisation as set out in IAS 38 `Intangible assets' have not been met.
5 Segmental information
The directors consider that the company operates in one business segment.
The group's principal activity consists of the design, development, manufacture and sale of light emitting diode based arrays and light engines with turnover and loss on ordinary activities arising entirely from this activity.
The group's revenue is generated mainly from the UK, Europe and the US.
Revenue |
2008 £ |
2007 £ |
UK |
1,178,014 |
101,333 |
Europe |
120,463 |
28,869 |
US |
289,987 |
163,723 |
Other countries |
39,538 |
13,088 |
1,628,002 |
307,013 |
Revenue is allocated based on the country in which the customer is located.
6 Investments
Company |
2008 £ |
2007 £ |
Investment in subsidiary undertaking |
572,175 |
572,175 |
Name |
Country of incorporation |
Proportion of ownership interest |
Principal activities |
Enfis Limited |
England and Wales |
100% interest in Ordinary Share Capital |
Design, development, manufacture and sale of light emitting diode based arrays and light engines. |
On 16 March 2007, the entire issued share capital of Enfis Limited was acquired by Enfis Group plc.
The consideration payable in respect of this transaction was settled via a share for share exchange, whereby three ordinary shares in Enfis Group plc were exchanged for each allotted share in Enfis Limited.
Pursuant to this agreement, 5,271,754 Ordinary shares of £0.10 were issued to the shareholders of Enfis Limited.
7 Property, Plant and Equipment
Group |
Plant & Machinery £ |
Fixtures Fittings Tools & Equipment £ |
Total £ |
Cost |
|||
At 1 January 2007 |
235,502 |
41,006 |
276,508 |
Additions |
102,677 |
890 |
103,567 |
At 31 December 2007 |
338,179 |
41,896 |
380,075 |
Additions |
45,337 |
13,364 |
58,701 |
At 31 December 2008 |
383,516 |
55,260 |
438,776 |
Accumulated depreciation |
|||
At 1 January 2007 |
67,846 |
17,895 |
85,741 |
Charge for the year |
52,343 |
6,640 |
58,983 |
At 31 December 2007 |
120,189 |
24,535 |
144,724 |
Charge for the year |
67,889 |
8,588 |
76,477 |
At 31 December 2008 |
188,078 |
33,123 |
221,201 |
Net book value |
|||
At 31 December 2008 |
195,438 |
22,137 |
217,575 |
At 31 December 2007 |
217,990 |
17,361 |
235,351 |
The net book value of plant and machinery includes an amount of £27,606 (2007: £65,812) in respect of assets held under finance leases and hire purchase contracts.
The company has no fixed assets.
8 Intangible fixed assets
Group |
Patents & Licenses £ |
Development Costs £ |
Total £ |
Cost |
|||
At 1 January 2007 |
189,270 |
- |
189,270 |
Additions |
21,044 |
359,613 |
380,657 |
Disposals |
(93,617) |
- |
(93,617) |
At 31 December 2007 |
116,697 |
359,613 |
476,310 |
Additions |
46,129 |
269,658 |
315,787 |
At 31 December 2008 |
162,826 |
629,271 |
792,097 |
Amortisation |
|||
At 1 January 2007 |
68,137 |
- |
68,137 |
Charge for the year |
21,389 |
31,105 |
52,494 |
Released on disposal |
(44,255) |
- |
(44,255) |
At 31 December 2007 |
45,271 |
31,105 |
76,376 |
Charge for year |
26,225 |
107,132 |
133,357 |
Impairment |
41,917 |
- |
41,917 |
At 31 December 2008 |
113,413 |
138,237 |
251,650 |
Net book value |
|||
At 31 December 2008 |
49,413 |
491,034 |
540,447 |
At 31 December 2007 |
71,426 |
328,508 |
399,934 |
Patents include the external third party cost associated with the acquisition of patents for internally developed intellectual property and know how. Intangible amortisation is recognised within administrative expenses in the income statement.
The costs associated with acquiring patents relating to technology which are not integral to the product range planned for market have been expensed to the income statement during the period. The impairment relates to the write off of patent costs associated with products that are no longer integral to the product range and are not being actively marketed for commercial sale.
The company has no intangible fixed assets.
9 Inventories
Group |
2008 £ |
2007 £ |
Raw materials and consumables |
351,108 |
277,876 |
Inventory totalling £45,423 relating to obsolete stock has been written-off and expensed to the income statement in the year.
The company has no inventories.
10 Trade and other receivables
Group 2008 £ |
Company 2008 £ |
Group 2007 £ |
Company 2007 £ |
|
Trade receivables |
169,700 |
- |
123,092 |
- |
Less: provision for impairment of trade receivables |
(4,601) |
- |
(10,892) |
- |
Trade receivables (net) |
165,099 |
- |
112,200 |
- |
Amounts due from subsidiary undertaking |
- |
4,433,522 |
- |
3,906,875 |
Prepayments |
41,810 |
- |
40,596 |
- |
Unpaid share capital |
441 |
- |
441 |
- |
Other receivables |
11,023 |
- |
58,625 |
- |
218,373 |
4,433,522 |
211,862 |
3,906,875 |
|
Less non current portion: amounts due from subsidiary undertakings |
- |
(4,433,522) |
- |
(3,906,875) |
Current portion |
218,373 |
- |
211,862 |
- |
Amounts due from subsidiary undertakings represent net amounts provided to the company's wholly owned subsidiary Enfis Limited. The net amount is unsecured and is repayable on the basis that one year's notice is required.
The fair value of trade and other receivables at 31 December 2007 and 31 December 2008 approximate to the book value stated above.
As of 31 December 2008, trade receivables of £10,514 (2007: £10,832) were past due but not impaired. These relate to a number of independent customers for whom there is no recent history of default. The ageing analysis of these trade receivables is as follows:-
2008 £ |
2007 £ |
|
3 to 6 months |
2,494 |
2,815 |
Over 6 months |
8,020 |
8,017 |
10,514 |
10,832 |
10 Trade and other receivables (continued)
As of 31 December 2008, trade receivables of £4,601 (2007: £10,892) were impaired. The individually impaired receivables mainly relate to old balances where it has been assessed that the receivable is not expected to be recovered. The ageing of these receivables is as follows:
2008 £ |
2007 £ |
|
Over 6 months |
4,601 |
10,892 |
The carrying amounts of the group's trade and other receivables are denominated in the following currencies:
2008 £ |
2007 £ |
|
UK pound |
201,061 |
162,083 |
Euros |
6,908 |
15,363 |
US dollar |
10,404 |
34,416 |
218,373 |
211,862 |
Movements on the provision for impairment of trade receivables are as follows:
2008 £ |
2007 £ |
|
At 1 January |
10,892 |
33,962 |
Specific write off |
(10,376) |
(33,962) |
Provision for receivables impairment |
4,085 |
10,892 |
At 31 December |
4,601 |
10,892 |
11 Cash and cash equivalents
Cash and cash equivalents consist of cash on hand and balances with banks, and investments in money market instruments. Cash and cash equivalents included in the cash flow statement comprise the following balance sheet amounts.
Group 2008 £ |
Company 2008 £ |
Group 2007 £ |
Company 2007 £ |
|
Cash on hand and balances with banks |
315,464 |
2 |
18,414 |
2 |
Short-term investments (Treasury Deposits) |
325,480 |
- |
1,981,010 |
- |
640,944 |
2 |
1,999,424 |
2 |
Significant non-cash transactions
As disclosed in note 12, on 16 March 2007, the entire issued share capital of Enfis Limited was acquired by Enfis Group plc. The consideration payable in respect of this transaction was settled via a share for share exchange, whereby three ordinary shares in Enfis Group plc were exchanged for each allotted share in Enfis Limited. Pursuant to this agreement, 5,721,754 Ordinary shares were issued to the shareholders of Enfis Limited.
12 Share capital
The authorised and issued share capital of Enfis Group plc is summarised below:
2008 £ |
2007 £ |
|
Authorised: |
||
15,000,000 ordinary shares of £0.10 each (On incorporation 50,000 ordinary shares of £1 each) |
1,500,000 |
1,500,000 |
Issued, allotted and fully paid: |
||
9,382,863 Ordinary shares of £0.10 each |
938,286 |
893,606 |
The Company was incorporated on 1 March 2007 with an authorised share capital of £50,000 comprising 50,000 ordinary shares of £1 each.
On 1 March 2007, the Company allotted 2 £1 Ordinary shares for cash fully paid.
On 16 March 2007 the Company by written resolution:
subdivided the two existing ordinary shares of £1 and re-designated them into 20 ordinary shares of 10 pence each;
subdivided the existing 49,998 authorised but unissued ordinary shares of £1 each and re-designated them into 499,980 ordinary shares of 10 pence each;
Increased its authorised share capital to £1,500,000 divided into 15,000,000 ordinary shares of 10 pence each, by the creation of 14,500,000 new Ordinary Shares of 10 pence each;
Authorised the Directors to allot relevant securities pursuant to Section 80 of the Act up to an aggregate nominal value of £1,500,000 for the period until the annual general meeting of the Company in 2008, unless previously revoked or varied by the Company in general meeting.
On 21 February 2008, the Company issued 446,804 £1 Ordinary shares at a price of 120.5 pence per share raising £538,398 before expenses of £11,751.
The table below reconciles movements in issued share capital during the year.
Number of shares |
Ordinary share capital £ |
Share premium £ |
Total £ |
|
At 1 January 2008 |
8,936,060 |
893,606 |
3,585,446 |
4,479,052 |
Share issue |
446,804 |
44,680 |
481,967 |
526,647 |
At 31 December 2008 |
9,382,864 |
938,286 |
4,067,413 |
5,005,699 |
12 Share capital (continued)
Share Options
Enfis Group plc has an Enterprise Management Incentive Share Option Scheme (EMI Scheme) and an Executive Share Option Scheme.
During the year, 71,500 share options (2007: 1,096,350) to subscribe for Ordinary Shares have been granted to directors and to selected employees under the EMI Scheme.
The exercise price of granted options is set out below:
Granted 2008 Options at Exercise price of £1.055 |
Granted 2007 Options at exercise price of 0.1 pence |
Granted 2007 Options at exercise price of £1.15 |
Granted 2007 Options at exercise price of 72 pence |
|
Number of options |
71,500 |
666,000 |
120,000 |
310,350 |
Enfis Limited previously operated an un-approved share option scheme for its directors and employees. On 16 March 2007, holders of options in the Enfis Limited scheme exchanged their options for options in the EMI Scheme operated by Enfis Group plc.
Options are conditional on the employee remaining within the employment of the group on the exercise date (the vesting period). Options issued under the EMI scheme are exercisable as follows:
In respect of the Options over Ordinary shares granted at 0.1 pence, the Options shall be exercisable from 23 March 2007 at the subscription price of 0.1 pence.
In respect of Options over Ordinary shares granted at £1.15, the option shall be exercisable at the subscription price of £1.15 as follows:-
As to 25% of the relevant Ordinary shares with effect from 23 March 2007
As to a further 25% with effect from 2 January 2008: and
As to a further 25% with effect from 2 January 2009: and
As to the final 25%, with effect from 2 January 2010.
In respect of Options over Ordinary shares granted at 72 pence, the option shall be exercisable at the subscription price of 72 pence as follows:-
As to 25% of the relevant Ordinary shares with effect from 11 January 2008
As to a further 25% with effect from 11 January 2009: and
As to a further 25% with effect from 11 January 2010: and
As to the final 25%, with effect from 11 January 2011.
In respect of options over ordinary shares granted at £1.055, the option shall be exercisable at the subscription price of £1.055 as follows:-
As to 25% of the relevant Ordinary shares with effect from 13 May 2009
As to a further 25% with effect from 13 May 2010: and
As to a further 25% with effect from 13 May 2011: and
As to the final 25%, with effect from 13 May 2012
12 Share capital (continued)
Movements in the number of share options outstanding and their related weighted average exercise prices are as follows:
Average exercise per share |
Options Number |
|
At 1 January 2007 in Enfis Limited |
265,000 |
|
Converted in consideration for new options |
(265,000) |
|
At 16 March 2007 |
- |
|
Enfis Plc |
||
At 15 March 2007 |
- |
|
Granted - 16 March 2007 |
0.1 pence |
666,000 |
Granted - 16 March 2007 |
115 pence |
120,000 |
Granted - 16 March 2007 |
72 pence |
310,350 |
At 31 December 2007 |
1,096,350 |
|
Granted - 13 May 2008 |
105.5 pence |
71,500 |
Forfeited |
0.1 pence |
(15,000) |
Forfeited |
115 pence |
(28,500) |
Forfeited |
72 pence |
(36,300) |
At 31 December 2008 |
1,088,050 |
Share options outstanding at the end of the year have the following expiry date and exercise prices:
Expiry date |
Exercise price per share |
Shares 2008 |
Shares 2007 |
2013 - expiry date 23 July |
0.1pence |
651,000 |
666,000 |
2016 - expiry date 2 January |
115 pence |
91,500 |
120,000 |
2017 - expiry date 2 January |
72 pence |
274,050 |
310,350 |
2018 - expiry date 13 May |
105.5 pence |
71,500 |
- |
1,088,050 |
1,096,350 |
The weighted average fair value of the options with an exercise price of 0.1 pence granted on 16 March 2007, determined using the Black-Scholes valuation model, was 140p per option. The significant inputs into the model were weighted average share price of 140p at the grant date, exercise price of 0.1 pence, volatility of 50%, risk free rate of 5.14% and a dividend stream of nil.
The weighted average fair value of the options with an exercise price of 115 pence granted on 16 March 2007, determined using the Black-Scholes valuation model, was 47p per option. The significant inputs into the model were weighted average share price of 140p at the grant date, exercise price of 115 pence, volatility of 50%, risk free rate of 5.14% and a dividend stream of nil.
The weighted average fair value of the options with an exercise price of 72 pence granted on 16 March 2007, determined using the Black-Scholes valuation model, was 82p per option. The significant inputs into the model were weighted average share price of 140p at the grant date, exercise price of 72 pence, volatility of 50%, risk free rate of 5.14% and a dividend stream of nil.
The weighted average fair value of the options with an exercise price of 105.5 pence granted on 13 May 2008, determined using the Black-Scholes valuation model, was 70.6p per option. The significant inputs into the model were weighted average share price of 105.5p at the grant date, exercise price of 105.5p, volatility of 50%, risk free rate of 4.80% and a dividend stream of nil.
13 Trade and other payables
Group |
2008 £ |
2007 £ |
Trade payables |
220,868 |
328,618 |
Social security and other taxes |
78,766 |
67,646 |
Other payables |
489 |
497 |
Accruals |
102,477 |
68,285 |
Deferred income - government grants |
30,000 |
30,000 |
432,600 |
495,046 |
The Company has no trade or other payables.
14 Non current liabilities - deferred income
Group |
2008 £ |
2007 £ |
Deferred income - government grants |
35,000 |
65,748 |
The Company has no deferred income.
15 Borrowings
Group |
2008 £ |
2007 £ |
Current borrowings |
||
Bank loan |
30,300 |
30,300 |
Obligations under finance leases and hire purchase contracts |
17,730 |
28,138 |
48,030 |
58,438 |
|
Non-current borrowings |
||
Bank loan |
58,075 |
88,375 |
Obligations under finance leases and hire purchase contracts |
- |
17,730 |
58,075 |
106,105 |
The Company has no borrowings.
15 Borrowings (continued)
Bank borrowings
Bank loan |
2008 £ |
2007 £ |
Amounts falling due: |
||
Between one and two years |
30,300 |
30,300 |
Between three and five years |
27,775 |
58,075 |
Total due after more than one year |
58,075 |
88,375 |
Due within one year |
30,300 |
30,300 |
Bank borrowings mature on December 2011 and bear interest of 2.5% over Base Rate (2007: 2.5% over Base Rate). Undrawn facilities at 31 December 2008 include a floating rate bank overdraft of £358,000 (2007: £358,000).
Total borrowings include secured bank loans and finance lease liabilities of £106,105 (2007: £164,543).
The bank loan is repayable in 60 monthly instalments commencing December 2006. Interest on the loan is payable quarterly at 2.5% above base rate. A guarantee premium of 2% per annum is also payable quarterly in advance. The loan is guaranteed by the Department of Trade and Industry under the Small Firm Loan Guarantee Scheme (SFLG).
The loan is secured by way of a fixed and floating charge over the assets of Enfis Limited.
Finance leases
2008 £ |
2007 £ |
|
Finance lease liabilities - minimum lease payments: |
||
No later than one year |
18,478 |
30,763 |
Later than one year no later than 5 years |
- |
18,478 |
18,478 |
49,241 |
|
Future finance charges on finance leases |
(748) |
(3,373) |
Present value of finance lease liabilities |
17,730 |
45,868 |
The present value of finance lease liabilities is as follows: |
||
No later than one year |
17,730 |
28,138 |
Later than one year and no later than five years |
- |
17,730 |
17,730 |
45,868 |
Lease liabilities are effectively secured as the rights to the leased asset revert to the lessor in the event of default.
The company has the option to purchase the assets held under finance leases at the end of the lease agreements for a nominal value.
15 Borrowings (continued)
The exposure of the company's bank borrowings and finance lease debt to interest rate changes and the contractual re-pricing dates at the balance sheet dates are as follows:
2008 £ |
2007 £ |
|
12 months or less |
30,300 |
30,300 |
1-5 years |
58,075 |
88,375 |
88,375 |
118,675 |
The carrying amounts and fair value of non-current borrowings are as follows:
Carrying amount |
Fair value |
|||
2008 £ |
2007 £ |
2008 £ |
2007 £ |
|
Bank loan |
58,075 |
88,375 |
58,075 |
88,375 |
Obligations under finance leases |
- |
17,730 |
- |
17,730 |
58,075 |
106,105 |
58,075 |
106,105 |
The fair value of bank and finance lease borrowings approximates to their carrying amounts.
16 Deferred income tax
There is an un-provided deferred tax asset of £562,918 (2007: £825,304). The deferred tax asset has not been recognised in the 31 December 2008 or 31 December 2007 financial statements on the grounds of uncertainty surrounding its current recoverability. The composition of the deferred tax asset which has not been recognised in the financial statements is:
Group |
2008 £ |
2007 £ |
Un-provided deferred taxation comprises: |
||
Accelerated capital allowances |
25,937 |
26,108 |
Tax losses |
(626,300) |
(628,761) |
Other timing differences |
37,445 |
(222,651) |
Un-provided deferred taxation |
(562,918) |
(825,304) |
Deferred tax is calculated on the temporary differences under the liability method using a tax rate of 21% (2007: 22%).
17 Expenses by nature
Group |
2008 £ |
2007 £ |
Raw materials and consumables used (sales) |
1,126,063 |
268,906 |
Raw materials and consumables used (development) |
216,084 |
331,103 |
Employee benefit expense (note 19) |
1,225,477 |
1,140,516 |
Depreciation and amortisation |
210,017 |
111,477 |
Patents written off (note 8) |
41,917 |
49,362 |
Operating lease payments |
55,818 |
47,281 |
Other expenses |
756,189 |
628,998 |
Total cost of sales and administrative expenses |
3,631,565 |
2,577,643 |
Raw materials and consumables used includes £216,084 (2007: £331,103) and employee benefit expense includes £590,274 (2007: £544,565) of development costs associated with the development of products. The development costs have been written off in the period on the basis that the directors do not believe that the company has satisfied the adequacy of financial resource test set out in IAS 38 `Intangible assets'.
Other expenses include £2,732 (2007: £3,528) of foreign exchange losses.
18 Auditors Remuneration
During the year the company obtained the following services from the company's auditors at costs as detailed below:
2008 £ |
2007 £ |
|
Fees payable to company's auditor for the audit of parent company and consolidated financial statements |
7,000 |
7,000 |
Fees payable to the company's auditor and its associates for other services: |
||
- The audit of the company's subsidiary pursuant to legislation |
6,000 |
6,000 |
- Tax services |
2,500 |
2,500 |
- Other services pursuant to legislation |
- |
19,000 |
- Other services in connection with AIM listing |
- |
80,000 |
Total |
15,500 |
114,500 |
19 Employee benefit expense
Group |
2008 £ |
2007 £ |
Wages and salaries |
1,039,668 |
972,168 |
Social security costs |
103,477 |
106,599 |
Share based payments |
82,332 |
61,749 |
1,225,477 |
1,140,516 |
The average monthly number of persons (including executive directors) employed by the group during the year was:
By activity |
2008 Number |
2007 Number |
Research and development |
14 |
14 |
Sales |
6 |
7 |
Administration and finance |
5 |
5 |
25 |
26 |
The Company incurred expenses of £82,332 (2007: £61,749) in respect of share based payments.
20 Finance income
Group |
2008 £ |
2007 £ |
Bank interest receivable |
54,434 |
124,215 |
21 Finance costs
Group |
2008 |
2007 |
£ |
£ |
|
Bank loans and overdrafts |
18,707 |
20,372 |
Finance charges payable under finance leases and hire purchase contracts |
2,625 |
5,827 |
Other |
- |
14,486 |
21,332 |
40,685 |
22 Directors' emoluments
Group |
2008 £ |
2007 £ |
Aggregate emoluments |
292,000 |
279,696 |
The services of Mr S Gibson are of a non executive nature. The emoluments of Mr S Gibson (£10,000) are invoiced to the Company by Fishstone Limited, the company paying his emoluments.
Key management is defined as directors. The analysis of key management compensation is therefore set out above.
The emoluments of the highest paid director were as follows:
Group |
2008 £ |
2007 £ |
Aggregate emoluments |
94,500 |
93,900 |
No share options were exercised by the highest paid director in the year (2007: nil). The highest paid director received no share options or other share based awards during the year.
22 Directors' emoluments (continued)
Share options
Share options granted to the Directors under the Company's approved share option scheme are shown below:
31 December 2007 Number |
Issued Number |
Forfeited Number |
31 December 2008 Number |
|
S J Gibson |
42,000 |
- |
- |
42,000 |
J C J Thynne |
42,000 |
- |
- |
42,000 |
Dr G Jones |
249,000 |
- |
- |
249,000 |
S P Oxenham |
249,000 |
- |
- |
249,000 |
G A Davies |
75,000 |
- |
- |
75,000 |
O G R Jones |
12,000 |
- |
- |
12,000 |
Dr. A W Nelson |
12,000 |
- |
- |
12,000 |
681,000 |
- |
- |
681,000 |
|
31 December 2007 Number |
Issued Number |
Forfeited Number |
31 December 2008 Number |
|
S J Gibson |
42,000 |
- |
- |
42,000 |
J C J Thynne |
42,000 |
- |
- |
42,000 |
Dr G Jones |
249,000 |
- |
- |
249,000 |
S P Oxenham |
249,000 |
- |
- |
249,000 |
G A Davies |
75,000 |
- |
- |
75,000 |
O G R Jones |
12,000 |
- |
- |
12,000 |
Dr. A W Nelson |
12,000 |
- |
- |
12,000 |
681,000 |
- |
- |
681,000 |
The period over which the above options are exercisable is summarised below:
Period of grant |
Number of options issued |
Price £ |
Period of exercise |
2007 |
420,000 |
0.001 |
2004 - 2013 |
2007 |
57,000 |
1.15 |
2007 - 2016 |
2007 |
204,000 |
0.72 |
2008 - 2017 |
Period of grant |
Number of options issued |
Price £ |
Period of exercise |
2007 |
420,000 |
0.001 |
2004 - 2013 |
2007 |
57,000 |
1.15 |
2007 - 2016 |
2007 |
204,000 |
0.72 |
2008 - 2017 |
23 Income tax credit
Group |
2008 |
2007 |
£ |
£ |
|
Current tax credit |
(555,789) |
(181,812) |
Deferred tax |
- |
- |
(555,789) |
(181,812) |
The tax on the group's loss before tax differs from the theoretical amount that would arise using the tax rate applicable to the losses of the group as follows:
2008 £ |
2007 £ |
|
Loss before tax |
(1,897,744) |
(2,046,865) |
Tax calculated at domestic tax rates applicable 21% (2007: 19%) |
(398,526) |
(388,904) |
Expenses not deductible for tax purposes |
(8,486) |
33,423 |
Additional deduction for R&D tax relief |
(118,734) |
- |
Losses surrendered for R&D tax credit |
356,201 |
- |
R&D tax credit |
(271,392) |
- |
Tax losses for which no deferred income tax asset was recognised |
169,545 |
355,481 |
Adjustments in respect of prior periods |
(284,397) |
(181,812) |
Total tax credit |
(555,789) |
(181,812) |
24 Net foreign exchange losses
The exchange differences (charged) to the income statement are included as follows:
Group |
2008 |
2007 |
£ |
£ |
|
Other (losses) - net |
(2,732) |
(3,528) |
(2,732) |
(3,528) |
25 Earnings per share
(a) Basic and diluted
Basic loss per share is calculated by dividing the profits attributable to equity holders of the company by the weighted average number of ordinary shares.
2008 |
2007 |
|
£ |
£ |
|
Loss attributable to equity holders of the company |
(1,341,955) |
(1,865,053) |
Weighted average number of ordinary shares |
9,319,383 |
8,211,919 |
Basic and diluted loss per share |
(14.4p) |
(22.7p) |
For the years ended 31 December 2008 and 2007, there was no difference in the weighted-average number of Ordinary Shares used for basic and diluted net loss per Ordinary Share as the effect of all potentially dilutive Ordinary Shares outstanding was anti-dilutive. As at 31 December 2008, there were share options outstanding of 1,088,050 shares (2007: 1,096,350 shares), which could potentially have a dilutive impact in the future, but which were anti-dilutive in 2008 and 2007.
26 Cash generated from operations
Group 2008 £ |
Group 2007 £ |
Company 2008 £ |
Company 2007 £ |
|
Loss before income tax |
(1,897,744) |
(2,046,865) |
(82,332) |
(61,749) |
Adjustments for: |
||||
- Depreciation |
76,477 |
58,983 |
- |
- |
- Amortisation - intangibles |
133,357 |
52,494 |
- |
- |
- Write-off of patents (note 8) |
41,917 |
49,362 |
- |
- |
- Amortisation - grants |
(30,748) |
(31,629) |
- |
- |
- Share based payments |
82,332 |
61,749 |
82,332 |
61,749 |
- Government grant income |
(41,969) |
(104,604) |
- |
- |
- Finance income |
(54,434) |
(124,215) |
- |
- |
- Finance costs |
21,332 |
40,685 |
- |
- |
Changes in working capital |
||||
- Inventories |
(73,232) |
(216,447) |
- |
- |
- Trade and other receivables |
(6,511) |
(131,419) |
- |
- |
- Trade and other payables |
(62,468) |
155,175 |
- |
- |
Cash used in operations |
(1,811,691) |
(2,236,731) |
- |
- |
27 Contingencies
The group received grant funding of £42,802 (2007: £140,235) during the year which could become repayable if certain conditions relating to the grant offer letter are not complied with during the post grant monitoring period. It is the director's opinion that they have complied fully with all of the grant conditions and that no amounts are repayable.
28 Commitments
(a) Capital commitments
There are no capital commitments at either year end.
(b) Operating lease commitments
The group leases a building under a non-cancellable landlords repairing lease from the Welsh Assembly Government.
The future aggregate minimum lease payments under this non-cancellable operating lease are as follows:
2008 £ |
2007 £ |
|
Expiring within 1 year |
9,303 |
- |
Expiring within 2 to 5 years |
- |
6,867 |
9,303 |
6,867 |
29 Related party transactions
The net proceeds derived from the share issue undertaken in Enfis Group plc in February 2008, amounting to £526,647 (note 12) were advanced to Enfis Limited to help fund the company's day to day operating cash flow requirements.
The cash advance has been treated as a loan. The loan is unsecured and is repayable on the basis that one years notice is required.
The net proceeds derived from the share issue undertaken in Enfis Group plc on admission to AIM on 16 March 2007, amounting to £3,906,875 (note 10) were advanced to Enfis Limited to help fund the company's day to day operating cash flow requirements.
The cash advance has been treated as a loan. The loan is unsecured and is repayable on the basis that one years notice is required.
During 2007 Enfis Limited sold lighting equipment totalling £35,250 to the Celtic Manor Resort Limited, a company which John C Thynne, a director of Enfis Group plc, is also a director. At 31 December 2007 an amount of £35,250 was due from the Celtic Manor Resort Limited in respect of the transaction.
30 Events after the balance sheet date
An Extraordinary General Meeting held on 6 April 2009, approved the issue of 5,600,000 £0.10 Ordinary shares, for a consideration of £0.36 per share, generating gross proceeds £2,016,000. The shares will formally be issued on 7 April 2009.
31 Controlling party
The directors consider there to be no ultimate controlling party.
Related Shares:
BOU.L